Pakistan Drug Makers Vow Price Increases Lacking Import Costs Relief
This article was originally published in PharmAsia News
Executive Summary
Pakistan's pharmaceutical industry is calling for relief from the government for the cost of raw materials they must import, threatening an increase in drug prices by as much as 20 percent